Device-Related Thrombosis in Continuous-Flow Left Ventricular Assist Device Support

Area of Science:

• Cardiology
• Biomedical Engineering
• Thrombosis Research

Background:

• Continuous-flow ventricular assist devices (CF-LVADs) have transformed advanced heart failure treatment, enhancing survival and quality of life.
• Despite advancements, CF-LVAD therapy is complicated by a high incidence of major complications, particularly device-related thrombosis (DRT).
• DRT poses a significant threat, increasing morbidity and mortality in CF-LVAD recipients.

Purpose of the Study:

• To review and synthesize the current literature on device-related thrombosis in continuous-flow ventricular assist device recipients.
• To elucidate the complex pathophysiology and diagnostic challenges associated with CF-LVAD thrombosis.
• To summarize existing evidence on the management and prophylaxis strategies for CF-LVAD thrombosis.

Main Methods:

• Comprehensive literature search of existing studies on CF-LVAD thrombosis.
• Analysis of pathophysiology, diagnostic criteria, and treatment outcomes from case series and reports.
• Evaluation of current prophylaxis strategies, including antiplatelet and antithrombotic therapies.

Main Results:

• Device-related thrombosis is a major complication in CF-LVAD recipients, with evolving incidence rates.
• Pathophysiology involves intricate pump-specific and patient-specific factors.
• Evidence for treatment is limited, and prophylaxis strategies remain imprecise.

Conclusions:

• Device-related thrombosis is a critical challenge in CF-LVAD therapy requiring further investigation.
• Accurate diagnosis and effective management strategies are essential to mitigate morbidity and mortality.
• Standardized prophylaxis protocols are needed to optimize patient outcomes.